Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
CSBA Letter to Congressional Leaders on PBM, PPRV…
Dear Congressional Leaders:On behalf of the Council of State Bioscience Associations (CSBA)—a national coalition of independent, state and territory-based organizations representing the full breadth of America’s biotechnology ecosystem—we write to…
BIO's Comments on Advisory Committee on…
Re: Docket No. CDC-2025-0783; Advisory Committee on Immunization Practices (ACIP) MeetingDear Dr. Zadeh and Members of the ACIP:The Biotechnology Innovation Organization (BIO) appreciates the opportunity to provide comments to the Advisory Committee…
Testimony of BIO President & CEO John F. Crowley…
Chairman Cassidy, Ranking Member Sanders, and distinguished Members of the Committee:Thank you for the opportunity to appear before you today on behalf of the Biotechnology Innovation Organization (BIO), which represents more than 1,000…
All Letters, Testimony & Comments
  • Show All
Search
Results
March 17, 2021
The Biotechnology Innovation Organization (BIO) welcomes the United Kingdom’s (UK) consultation on the application of genome editing in the breeding of plants and animals.  The UK has the unique opportunity to be the first country within Europe…
March 11, 2021
The Biotechnology Innovation Organization is pleased to submit a statement for the record to the United States House of Representatives Committee on Agriculture hearing entitled, "A Look at Food Insecurity in America." The Committee's hearing…
March 11, 2021
The Biotechnology Innovation Organization (BIO) is pleased to submit a statement for the record to the United States Senate Committee on Agriculture, Nutrition, and Forestry hearing entitled, “Farmers and Foresters: Opportunities to Lead in Tackling…
March 8, 2021
BIO President and CEO Dr. Michelle McMurry-Heath sent President Biden a letter sharing thoughts on how to best work together with global partners to ensure that patients around the world get access to COVID vaccines, therapeutics, and…
March 3, 2021
The Biotechnology Innovation Organization (BIO) applauds the introduction of the Emergency Relief for Farmers of Color Act and welcomes the inclusion of provisions from this legislation in the American Rescue Plan.  BIO is committed to…
February 26, 2021
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Department of Agriculture’s (USDA’s) advance notice of proposed rulemaking and request for public comment on a proposed framework for oversight of certain…
February 26, 2021
Equality of opportunity is a key pillar of our great democracy—one that allows all people to pursue their American Dream—and part of what makes our nation exceptional. Our industries, representing and employing tens of millions of Americans,…
February 25, 2021
The Biotechnology Innovation Organization is pleased to submit a statement for the record to the United States House of Representatives Committee on Agriculture hearing entitled, "Climate Change and the U.S. Agriculture and Forestry Sectors." BIO…
February 21, 2021
On behalf of the Biotechnology Innovation Organization (BIO) – the world’s largest trade group for the biotechnology sector – I write to express support for Senate File 944, a bill you recently filed that would increase the minimum biofuel content…
February 9, 2021
The Biotechnology Innovation Organization is pleased to submit a statement for the record to the United States House of Representatives Committee on Energy and Commerce Subcommittee on Environment and Climate Change hearing entitled, "Back in Action…